Contenuto
Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »PRIN - Programmi di ricerca di Rilevante Interesse Nazionale»Programma di ricercaINIZIO_TESTO_DA_INDICIZZARE
RESEARCH PROGRAM
italiano - inglese
Research Units
- Università degli Studi di UDINE
SCIENZE E TECNOLOGIE BIOMEDICHE
UDINE(UD) - Università degli Studi di PADOVA
SCIENZE FARMACEUTICHE
PADOVA(PD) - Università degli Studi di FIRENZE
SCIENZE BIOCHIMICHE
FIRENZE(FI) - Università degli Studi di GENOVA
FISICA
GENOVA(GE) - Università degli Studi di PAVIA
BIOCHIMICA
PAVIA(PV) - Università degli Studi di NAPOLI "Federico II"
CHIMICA ORGANICA E BIOCHIMICA
NAPOLI(NA)
Similar research programs:
- 1 - AMYLOID AGGREGATION OF APOMYOGLOBIN: MOLECULAR MECHANISMS AND IDENTIFICATION OF AMYLOIDOGENIC AND CYTOTOXIC POLYPEPTIDE FRAGMENTS
- 2 - Molecular features of protein conformational diseases. Role of environmental factors on the structural changes of proteins for the design and the synthesis of agents with antiaggregating, antioxidant, antiglycating and chelating activity and for application in diagnostics.
- 3 - Role of metals – Ubiquitin/Proteasome interaction in the pathogenesis of conformational diseases
- 4 - A multidisciplinary approach to the study of in vivo and vitro aggregation of polyglutamine-containing proteins. Role of molecular and environmental factors.
- 5 - Chemical processes and structural modifications in neurodegeneration
- 6 - Protein folding and aggregation: a theoretical-experimental approach
- 7 - Role of molecular interactions in the acquisition of the functional structure of model proteins
- 8 - Structural genomics of metalloproteins and of their functional interactions
- 9 - Role of the metal ions in the aggregation processes of proteins.
- 10 - Identification of folding and misfolding determinants by site-directed mutagenesis.
Scientific and education field classification
- Field: Scienze fisiche
- Field: Scienze biologiche
International Patent Classification
- CHEMISTRY; METALLURGY
- ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
- PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
Geographical classification
- Region: Friuli Venezia Giulia
Keywords
PROTEIN MISFOLDING; AGGREGATION; AMYLOIDOGENIC PROTEINS; ANTIBODIES; PROTEIN FRAGMENTS; LIGANDS; METAL ION-PROTEIN INTERACTIONINTERACTION PARTNERS OF AMYLOIDOGENIC PROTEINS TO STUDY MISFOLDING AND AGGREGATION PROCESSES; POSSIBLE APPLICATIONS
Università degli Studi di UdineAbstract
Some human diseases with a relevant socioeconomic impact are caused by the formation of insoluble protein aggregates of fibrillar nature, referred to as amyloid deposits.The formation of these aggregates requires conformational modifications of the precursor proteins, which can be considered as a deviation from the normal protein folding process. Amyloid deposits, however, can also be formed by fragments, either structured or not, obtained by proteolytic events from larger precursor proteins. This project aims at studying proteins of either amyloidogenetic pathways. It has been shown that a large proportion of physiologically relevant amyloid deposits in tissues are made up by protein fragments derived from relatively larger protein precursors; on this basis, it is reasonable to propose the use of protein fragments as most suitable experimental systems for exploring the mechanisms of amyloid fibrils formation. On the other hand during the molecular process of fibrillar conversion of other proteins, aggregation requires a molecular destabilization phase and the formation of intermediate states that are stabilized by intramolecular interactions affecting the secondary structure. Fibrillogenesis can be modulated by the modification of chemical and physical conditions affecting protein solvation and the charge of a few key residues, but also by the interaction with natural or synthetic ligands. Metal ions appear important to this purpose because their binding can affect >>>
Principal Investigator
Paolo VIGLINO Università degli Studi di UDINEResearch Objectives
Aim of the project is to investigate three different topics regarding the aberrant assembly of proteins or protein fragments which lead to the formation of fibrils and plaques of amyloidogenic diseases.Six research units will collaborate to the realization of the project; three research units (Pavia, Firenze, Padova) are mainly involved in the expression or production of biological material (proteins, proteins fragments, antybodies etc), but also contribute to the characterization of thermodinamical, biochemical and kinetic parameters which control oligomerization and fibrillogenesis; the three other research units (Udine, Genova, Napoli) contribution is mainly due to the use of sophisticated techniques such as Atomic Force Microscopy, Multidimensional NMR spectroscopy and limited proteolysis, H/D exchange and chemical crosslinking coupled to Mass Spectroscopy.
- Studies on the aggregation of protein fragments. Amyloid deposits can be formed by fragments, either structured or not, obtained by proteolytic events from larger precursor proteins. Protein fragments can adopt in isolation partly folded states that expose hydrophobic patches that are usually hidden in the interior of a native intact protein. Therefore, fragments are capable of strong intermolecular hydrophobic interactions, thus leading to their association to form soluble oligomers, which constitute a critical nucleus of the overall process of fibrillogenesis towards the final, well-ordered mature >>>
First Results
In phase Ia several structural, thermodynamic and kinetic aspects of the fibrillogenic process of selected amyloidogenic proteins will be established. One of the predicted results is represented by the characterisation of intermediates of the folding/misfolding pathway stabilised by metal ions.In phase Ib the results are the antibodies that target b2microglobulin, Hypf and sinuclein. For each antibody exaustive characterisation of binding properties, and definition of structural properties of the epitope will be provided.The results will consist in the identification of antibodies and their fragments able to interfere with the fibrillogenic process and in the possible elucidation of mechanism of correction of fibrillogenic propensity of the protein model under investigation. Once the functional (anti-fibrillogenic) antibodies will be availabe and characterised, it will become affordable the definition of favourable modifications induced by the antibodies, regarding the tertiary structure, the surface topology and thermodynamic stability.
Timescale
24 monthsNational and international background
Some human pathologies with a great socioeconomic impact are caused by the formation of insoluble protein aggregates of fibrillar nature, referred to as amyloid deposits.The formation of these aggregates requires conformational modifications of the precursor proteins, in analogy to the onset of intermediate states along the normal protein folding process. Formation of such intermediates appears to be critical for the onset of fibril formation, since these species are capable of strong intermolecular interactions given by the exposure of the polypeptide main-chain and hydrophobic side-chains that are otherwise buried in the overall fold of the native protein [Dobson 2003]. This view has led to the proposal that all polypeptide chains in principle can form amyloid aggregates under appropriate experimental conditions [Dobson 1999]. However, since all fibrils derived from different proteins share a common structural motif, the cross beta-structure, it is clear that major conformational rearrangements should take place in order to produce the well-ordered protein aggregates. Nowadays, there is a common belief that partly folded or molten globule states of proteins can be key intermediates in protein aggregation and fibrillogenesis (Fink 1998). Amyloid deposits, however, can also be formed by fragments, either structured or not, obtained by proteolytic events from larger precursor proteins. This project aims at studying proteins of either amyloidogenetic pathways.
>>>



